Across the drug discovery and development pipeline, and through into healthcare delivery, data drives business decisions. Getting the best view of available information requires good access to data from both structured databases and in unstructured text.
In this webinar, Linguamatics and Cerenode will demonstrate how their combined technologies enables researchers to search and visualise valuable information across disparate sources. Looking at personalised medicine in lung cancer as an example; we will answer questions such as:
- Which companies are working on lung cancer?
- What are the current and potential protein targets in NSCLC?
- What drugs are on the market, and is there white space for novel targets?
- Are there gene variants that could enable patient stratification?
Presenters: Dr. David Milward, CTO, Linguamatics, Dr.Jane Reed, Head of Life Science Strategy, Linguamatics, Kalpana Krishnaswami, Founder and CEO, Cerenode
Duration: 40 minutes including Q&A
Who should attend?
Anyone with an interest in getting better value from their silo’ed data sources, both structured databases and unstructured textual information, working within the life sciences and healthcare.
- Informaticians, Information Professionals, Researchers, Managers, knowledge management professionals
- Therapeutic Areas
- Target ID/Validation
- Biomarker Discovery
- Systems Biology
- Translational Medicine
- Competitive Intelligence
About the presenters
Kalpana Krishnaswami is a founder at Cerenode and leads the Product Strategy and Sales. She is an expert in developing, managing and bringing new products to the market. She has over 20 years of experience in business and technical roles in the scientific computing industry. Previously, she has held various leadership positions in places such as GE, CambridgeSoft, Tripos, Instantiations (acquired by Google) and the North Carolina Supercomputing Centre at UNC-Chapel Hill. She also has extensive startup experience as the co-founder of Jigyasa, an e-learning startup and Metaome, a linked data search and analytics company. She holds an integrated MS degree from IIT-Delhi and a second MS degree in Computational Chemistry from Wright State University, USA.
Dr. David Milward is chief technology officer (CTO) at Linguamatics. He is a pioneer of interactive text mining, and a founder of Linguamatics. He has over 20 years experience of product development, consultancy and research in natural language processing (NLP). After receiving a PhD from the University of Cambridge, he was a researcher and lecturer at the University of Edinburgh. He has published in the areas of information extraction, spoken dialogue, parsing, syntax and semantics.
Dr. Jane Reed is the head of life science strategy. She is responsible for developing the strategic vision for Linguamatics’ growing product portfolio and business development in the life science domain. Jane has extensive experience in life sciences informatics. She worked for more than 15 years in vendor companies supplying data products, data integration and analysis and consultancy to pharma and biotech - with roles at Instem, BioWisdom, Incyte, and Hexagen. Before moving into life science industry, Jane worked in academia with post-docs in genetics and genomics.
Cerenode is a graph-based search and analytics company focussed on Life Sciences and Healthcare. Cerenode enables customers to segment and analyse Business and R&D data, using public vocabularies, ontologies, internal and external data sources. Cerenode's technology helps customers find insights by extracting specific segments of data and applying relevant analytics including machine learning and statistical methods.